RAD — Radiopharm Theranostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$48.41m
- AU$10.78m
- AU$0.30m
- 17
- 22
- 52
- 22
Annual cashflow statement for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Changes in Working Capital | — | 0.009 | 1.7 | 4.9 |
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.033 | -9.91 | -23.2 | -23 |
| Capital Expenditures | — | -28.3 | -1.53 | 0 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0 | -0.04 | 0 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -28.4 | -1.53 | 0 |
| Financing Cash Flow Items | — | -4.83 | -0.855 | -1.97 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.06 | 65.1 | 9.22 | 29.9 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.027 | 27 | -15.3 | 6.88 |